Literature DB >> 16900212

Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy.

L Lhermitte, A de Labarthe, C Dupret, H Lapillonne, C Millien, J Landman-Parker, O Hermine, A Baruchel, F Sigaux, E Macintyre, V Asnafi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16900212     DOI： 10.1038/sj.leu.2404349

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

2.  Interleukin-3 receptor α chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy.

Authors:  Wen Du; Juan Li; Wei Liu; Yanli He; Junxia Yao; Yu Liu; Jun Lin; Jine Zheng
Journal:  Tumour Biol       Date:  2015-10-16

3.  Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia.

Authors:  Miroslav Djokic; Elisabet Björklund; Elisabeth Blennow; Joanna Mazur; Stefan Söderhäll; Anna Porwit
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

4.  Targeting the alpha subunit of IL-3 receptor (CD123) in patients with acute leukemia.

Authors:  Ibrahim Aldoss; Mary Clark; Joo Y Song; Vinod Pullarkat
Journal:  Hum Vaccin Immunother       Date:  2020-07-21       Impact factor: 3.452

5.  SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia.

Authors:  Olga Frolova; Juliana Benito; Chris Brooks; Rui-Yu Wang; Borys Korchin; Eric K Rowinsky; Jorge Cortes; Hagop Kantarjian; Michael Andreeff; Arthur E Frankel; Marina Konopleva
Journal:  Br J Haematol       Date:  2014-06-19       Impact factor: 6.998

6.  Harnessing immunotherapy for pediatric T-cell malignancies.

Authors:  Caroline Diorio; David T Teachey
Journal:  Expert Rev Clin Immunol       Date:  2020-02-27       Impact factor: 5.124

7.  CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.

Authors:  Evgeniya Angelova; Charlene Audette; Yelena Kovtun; Naval Daver; Sa A Wang; Sherry Pierce; Sergej N Konoplev; Haitham Khogeer; Jeffrey L Jorgensen; Marina Konopleva; Patrick A Zweidler-McKay; L Jeffrey Medeiros; Hagop M Kantarjian; Elias J Jabbour; Joseph D Khoury
Journal:  Haematologica       Date:  2018-10-25       Impact factor: 9.941
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.